UBE2I and breast carcinoma: UBC9 (SUMO-conjugating enzyme) is frequently overexpressed in breast cancer, often 5-8-fold higher than in normal tissues, where it promotes tumor proliferation, invasion, and metastasis, often in a sumoylation-independent manner.